Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-25-000079
Filing Date
2025-01-02
Accepted
2025-01-02 16:15:30
Documents
1
Period of Report
2024-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3715
  Complete submission text file 0001140361-25-000079.txt   5326
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Issuer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O INTRA-CELLULAR THERAPIES, INC. 135 ROUTE 202/206 BEDMINSTER NJ 07921
Business Address
Salas Eduardo Rene (Reporting) CIK: 0001924188 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36728 | Film No.: 25502220